We are live on ! Find out more
VIM

Veritas Investment Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 25.54%
This Fund
S&P 500
This Quarter Est. Return
+9.65%
1 Year Est. Return
+25.54%
3 Year Est. Return
+69.01%
5 Year Est. Return
+144.34%
10 Year Est. Return
–
AUM
$210M
AUM Growth
+$37.4M
Cap. Flow
+$21M
Cap. Flow %
10%
Top 10 Hldgs %
77.9%
Holding
75
New
5
Increased
19
Reduced
10
Closed
7

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$13.3M
2
QCOM icon
Qualcomm
QCOM
+$3.64M
3
MSFT icon
Microsoft
MSFT
+$2.17M
4
CVS icon
CVS Health
CVS
+$1.18M
5
C icon
Citigroup
C
+$815K

Top Sells

Rank Stock Value
1
VAR
Varian Medical Systems, Inc.
VAR
+$2.56M
2
MRSH
Marsh
MRSH
+$1.76M
3
JEF icon
Jefferies Financial Group
JEF
+$659K
4
MO icon
Altria Group
MO
+$286K
5
DIS icon
Walt Disney
DIS
+$85.5K

Sector Composition

Rank Sector Weight
1 Technology 24.95%
2 Financials 24.68%
3 Healthcare 23.64%
4 Communication Services 11.68%
5 Consumer Staples 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KEY icon
26
KeyCorp
KEY
$24.4B
$746K 0.36%
55,554
+12,443
+29% +$157K
ORCL icon
27
Oracle
ORCL
$423B
$651K 0.31%
+17,000
New +$584K
DG icon
28
Dollar General
DG
$27.9B
$633K 0.3%
10,497
– –
UNP icon
29
Union Pacific
UNP
$174B
$619K 0.3%
7,370
– –
BNY
30
Bank of New York Mellon
BNY
$107B
$607K 0.29%
17,387
– –
FNV icon
31
Franco-Nevada
FNV
$46B
$595K 0.28%
+14,600
New +$613K
YUM icon
32
Yum! Brands
YUM
$41.1B
$582K 0.28%
10,704
– –
AMAT icon
33
Applied Materials
AMAT
$428B
$550K 0.26%
31,108
+8,900
+40% +$155K
BN icon
34
Brookfield
BN
$108B
$544K 0.26%
59,799
– –
ALGN icon
35
Align Technology
ALGN
$12.3B
$531K 0.25%
9,292
– –
CVX icon
36
Chevron
CVX
$366B
$525K 0.25%
4,200
– –
MRK icon
37
Merck
MRK
$318B
$525K 0.25%
10,992
– –
JNJ icon
38
Johnson & Johnson
JNJ
$625B
$504K 0.24%
5,500
+3,000
+120% +$276K
HSY icon
39
Hershey
HSY
$36.6B
$361K 0.17%
3,710
+2,150
+138% +$207K
AAPL icon
40
Apple
AAPL
$4.57T
$342K 0.16%
17,080
+980
+6% +$18.5K
WEC icon
41
WEC Energy
WEC
$35.1B
$323K 0.15%
7,810
– –
XYL icon
42
Xylem
XYL
$28.1B
$280K 0.13%
8,100
– –
ABBV icon
43
AbbVie
ABBV
$435B
$275K 0.13%
5,200
+3,000
+136% +$147K
XOM icon
44
ExxonMobil
XOM
$634B
$267K 0.13%
2,640
– –
IPG
45
DELISTED
Interpublic Group of Companies
IPG
$266K 0.13%
+15,000
New +$253K
EMR icon
46
Emerson Electric
EMR
$88.3B
$246K 0.12%
+3,500
New +$234K
CSX icon
47
CSX Corp
CSX
$93.1B
$230K 0.11%
+24,000
New +$215K
IBM icon
48
IBM
IBM
$224B
$225K 0.11%
1,255
– –
EMC
49
DELISTED
EMC CORPORATION
EMC
$217K 0.1%
8,643
-1,440
-14% -$34.9K
MDT icon
50
Medtronic
MDT
$112B
$211K 0.1%
3,669
– –
1
2
3

Similar funds

TI
TT International London, United Kingdom $1.94B AUM
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
CT
CGM Trust Boston, Massachusetts $957M AUM
CAW
Cornerstone Advisors (Washington) Bellevue, Washington $936M AUM 8.77% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
SFSG
Stearns Financial Services Group Greensboro, North Carolina $639M AUM 11.66% 1-Year Est. Return
KFA
Kays Financial Advisory Atlanta, Georgia $624M AUM 9.93% 1-Year Est. Return

Veritas Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Veritas Investment Management held 75 positions worth $210M, up 22% from $172M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Veritas Investment Management deployed $21M of net new capital in Q4 2013, opening 5 new positions and adding to 19 existing holdings. Its largest new stake was Franco-Nevada: 14,600 shares worth $595K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Varian Medical Systems, Inc., an estimated $2.56M trimmed.

  • Veritas Investment Management's largest Q4 2013 buy was Franco-Nevada: 14,600 shares worth $595K.
  • Veritas Investment Management added most to UnitedHealth in Q4 2013, an estimated $13.3M increase.
  • Veritas Investment Management's biggest Q4 2013 reduction was Varian Medical Systems, Inc., cutting an estimated $2.56M.
  • Veritas Investment Management fully exited Sotheby's in Q4 2013, selling an estimated $49K.
  • Veritas Investment Management's ten largest holdings make up 78% of its $210M portfolio in Q4 2013.
  • Veritas Investment Management opened 5 new positions and closed 7 in Q4 2013.
  • Veritas Investment Management's portfolio value rose 22% quarter-over-quarter to $210M.

Based on Veritas Investment Management's 13F filing for Q4 2013, filed 12 Feb 2014.